Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • ROOMS:

Why investors ponied up $76M for this company's new approach to Alzheimer's

Leaders of this 12-person company say their experimental drug, which will enter a mid-stage clinical trial next year, attacks a specific bacteria at the root of Alzheimer's inflammation and protein tangles in the brain.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.